FDA Drug Application (202122) for ENTECAVIR by TEVA PHARMS USA

Back to FDA Applications sponsored by TEVA PHARMS USA

Application Number202122
Product Number001
FormTABLET;ORAL
Dosage0.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameENTECAVIR
Active IngredientENTECAVIR

Active IngredientCount
List of drugs with Active Ingredient ENTECAVIR2


Back to FDA Applications sponsored by TEVA PHARMS USA